• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类多发性骨髓瘤骨病的体内模型。

An in vivo model of human multiple myeloma bone disease.

作者信息

Alsina M, Boyce B F, Mundy G R, Roodman G D

机构信息

University of Texas Health Science Center at San Antonio, USA.

出版信息

Stem Cells. 1995 Aug;13 Suppl 2:48-50.

PMID:8520511
Abstract

Osteolytic bone destruction and its complications, such as hypercalcemia, pathologic fractures and nerve compression, are the major source of morbidity in patients with multiple myeloma (MM). The bone destruction in MM is due to increased osteoclast activity, but the mechanisms responsible are not entirely clear. We have utilized a human plasma cell leukemia cell line, ARH-77, that has disseminated growth in mice with severe combined immunodeficiency (SCID) and expresses immunoglobulin G kappa (IgG kappa), as a model for human MM. Fifteen SCID mice were irradiated with 400R and 10 of these were injected with 10(6) ARH-77 cells i.v., 24 h after irradiation. Five mice were used as a control group. Development of bone disease was assessed by blood calcium levels, x-rays and histology. Seven out of seven mice that survived irradiation and received ARH-77 cells developed hind limb paralysis 28-35 days after injection. One hundred percent of these mice developed hypercalcemia (1.35-1.46 mmol/l), a mean of five days after becoming paraplegic. Lytic bone lesions were detected by x-ray in all the hypercalcemic mice examined. No lytic lesions or hypercalcemic developed in the controls. Mice were then sacrificed after developing hypercalcemia. Histologic examination of the ARH-77 mice showed infiltration of myeloma cells in the liver and spleen. Marked infiltration by the tumor was found in vertebrae and long bones, with loss of bony trabeculae and increased osteoclast numbers.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

溶骨性骨破坏及其并发症,如高钙血症、病理性骨折和神经受压,是多发性骨髓瘤(MM)患者发病的主要原因。MM中的骨破坏是由于破骨细胞活性增加,但具体机制尚不完全清楚。我们利用一种人类浆细胞白血病细胞系ARH-77,它在严重联合免疫缺陷(SCID)小鼠中呈播散性生长并表达免疫球蛋白G κ(IgG κ),作为人类MM的模型。15只SCID小鼠接受400R照射,其中10只在照射后24小时静脉注射10(6)个ARH-77细胞。5只小鼠作为对照组。通过血钙水平、X射线和组织学评估骨病的发展。7只存活下来并接受ARH-77细胞注射的小鼠中有7只在注射后28 - 35天出现后肢麻痹。这些小鼠中有100%出现高钙血症(1.35 - 1.46 mmol/l),平均在截瘫后5天出现。在所有检测的高钙血症小鼠中通过X射线检测到溶骨性骨病变。对照组未出现溶骨性病变或高钙血症。小鼠出现高钙血症后处死。对ARH-77小鼠的组织学检查显示骨髓瘤细胞浸润肝脏和脾脏。在椎骨和长骨中发现肿瘤明显浸润,骨小梁消失且破骨细胞数量增加。(摘要截断于250字)

相似文献

1
An in vivo model of human multiple myeloma bone disease.人类多发性骨髓瘤骨病的体内模型。
Stem Cells. 1995 Aug;13 Suppl 2:48-50.
2
Development of an in vivo model of human multiple myeloma bone disease.人类多发性骨髓瘤骨病体内模型的建立。
Blood. 1996 Feb 15;87(4):1495-501.
3
Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease.人多发性骨髓瘤细胞系在严重联合免疫缺陷病小鼠中的播散性生长。
Cancer Res. 1993 Mar 15;53(6):1392-6.
4
Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells.抗CD54(细胞间黏附分子-1)对携带人骨髓瘤细胞的SCID小鼠具有抗肿瘤活性。
Cancer Res. 1995 Feb 1;55(3):610-6.
5
Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.白细胞介素-18抑制人多发性骨髓瘤细胞在骨髓中的着床及后续生长。
Oncol Rep. 2002 Nov-Dec;9(6):1237-44.
6
Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice.人多发性骨髓瘤细胞系在严重联合免疫缺陷(SCID)小鼠中的异种移植。
Anticancer Res. 1993 May-Jun;13(3):593-7.
7
Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice.
J Bone Miner Res. 1999 Feb;14(2):256-63. doi: 10.1359/jbmr.1999.14.2.256.
8
RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.RANK-Fc:骨髓瘤中RANK-L的治疗性拮抗剂
Cancer. 2003 Feb 1;97(3 Suppl):802-12. doi: 10.1002/cncr.11134.
9
Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.在人骨髓瘤的体内模型中,伊班膦酸盐可减少骨病发展及破骨细胞刺激活性。
Exp Hematol. 2001 Apr;29(4):441-7. doi: 10.1016/s0301-472x(01)00618-x.
10
LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma.LAGlambda-1:一种具有临床相关性的耐药性人类多发性骨髓瘤肿瘤小鼠模型,可快速评估多发性骨髓瘤的治疗方法。
Int J Oncol. 2006 Jun;28(6):1409-17.

引用本文的文献

1
IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.白细胞介素-6样细胞因子与癌症恶病质:慢性炎症的后果
Immunol Res. 2001;23(1):41-58. doi: 10.1385/IR:23:1:41.
2
Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse.C57BL/KaLwRij小鼠中5T2和5T33骨髓瘤细胞的器官受累情况及表型黏附特征
Br J Cancer. 1997;76(4):451-60. doi: 10.1038/bjc.1997.409.